Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1Bladder instillation WITH triamcinolone acetonide[1] Triamcinolone (Triamcinolone Acetonide Injectable Suspension USP)[1] Triamcinolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 226 💬
2Bladder instillation WITHOUT triamcinolone acetonide[1] Triamcinolone (Triamcinolone Acetonide Injectable Suspension USP)[1] Triamcinolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 226 💬
3Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP[5] Dapsone,
Mycophenolate mofetil,
Mycophenolic acid,
Prednisolone,
Triamcinolone (Triamcinolone Acetonide Injectable Suspension USP)		[5] Triamcinolone ,
Prednisolone ,
Dapsone ,
Mycophenolate mofetil ,
Mycophenolic acid 💬 		[3] IMPDH1,
IMPDH2,
NR3C1 💬 		[5] Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬[1] 162 💬
4Triamcinolone Acetonide[1] Triamcinolone (Triamcinolone Acetonide Injectable Suspension USP)[1] Triamcinolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[3] 35, 46, 56 💬
5Triamcinolone Acetonide and normal saline solution[1] Triamcinolone (Triamcinolone Acetonide Injectable Suspension USP)[1] Triamcinolone 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 70 💬